Organic hyperinsulinism and hypoglycemia due to coexistence of islet cell adenomatosis, nesidioblastosis, and hyperplasia in a patient with type 2 diabetes

Endocrinologist

Volumn 9, Issue 5, 1999, Pages 391-394

  Espinosa De Los Monteros, Ana Laura ^a   Mendoza, Victoria ^a   Mier, Juan ^a   Cabrera, Lourdes ^a   Mercado, Moisés ^a,b  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMYOMATOSIS; ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERINSULINISM; HYPOGLYCEMIA; INSULINOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL HYPERPLASIA; PANCREAS ISLET CELL TUMOR; PATHOPHYSIOLOGY;

EID: 0032862099     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-199909000-00011     Document Type: Article

References (36)

1. Vinik A, Renar IP: Insulin producing tumors. Adv Endocrinol Metab 1993; 4: 1-27.
2. Stefanini P, Carboni M, Patrassi N, Basoli A: Hyperglycemia and insular hyperplasia: review of 148 cases. Ann Surg 1974; 180: 130-5.
3. Stefanini P, Carboni M, Patrassi N, Basoli A: Beta islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery 1974; 75: 597-609.
4. Case Records of the Massachusetts General Hospital (Case 30-1978). N Engl J Med 1978; 299: 241-8.
5. Buchner F: Inselzellenadenom des pankreas mit hypoglykamie bel diabetes. Klin Wochenschr 1932; 11: 1494-502.
6. Rae M, Lewis R: Islet cell tumor in diabetes mellitus: report of two cases. Can Med Assoc J 1957; 77: 69-72.
7. Gittler R, Zucker G, Eisinger R, Stoller N: Amelioration of diabetes mellitus by an insulinoma. N Engl J Med 1958; 258: 932-5.
8. Kane L, Grant C, Nippoldt T, Service F: Insulinoma in a patient with NIDDM. Diabetes Care 1993; 16: 1298-300.
9. Grunberger G: Insulin resistance in a case of coexisting insulinoma and type 2 diabetes. Acta Diabetol 1993; 30: 243-50.
10. Assan R, Hanania G, Lambert P, Marteau J, Camillieri J, Rosselin G: Tumeur beta-langer-hansienne insulino secretante chez una femme atteinte de diabete sucre. Une observation et reserve de la letterature. Ann Med Interne (Paris) 1969; 120: 173-64.
11. Svartberg J, Stridsberg M, Wilander E, Andersson D, Eriksson B: Tumor-induced hypoglycemia in a patient with insulin dependent diabetes mellitus. J Intern Med 1996; 239: 181-5.
12. Heik S, Kloppel G, Krone W, Iben G, Priebe K, Kuhnau J: Hypoglycemia caused by insulinoma in diabetes mellitus. Dtsch Med Wochenschr 1988; 113: 1714-7.
13. Sandler R, Horwitz D, Rubenstein A, Kuzuya H: Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Am J Med 1975; 59: 730-6.
14. Bell D, Grizzle W, Dunlap N: Nesidioblastosis causing reversal of insulin dependent diabetes and development of hyperinsulinemic hypoglycemia. Diabetes Care 1995; 18: 1379-80.
15. Jaffe R, Hashida Y, Yunis EJ: Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab Invest 1980; 42: 356-65.
16. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 1981; 29: 577-80.
17. Dahms BB, Landing BH, Blaskovics M, Roe TF: Nesidioblastosis and other islet cell abnormalities in hyperinsulinemic hypoglycemia in childhood. Hum Pathol 1980; 11: 641-9.
18. Case Records of the Massachusetts General Hospital. (Case 51-1983). N Engl J Med 1983; 308: 30-7.
19. Goudswaard WB, Houthoff HJ, Koudstaal J, Zwierstra RP: Nesidioblastosis and endocrine hyperplasia of the pancreas: a secondary phenomenon. Hum Pathol 1986; 17: 46-53.
20. Harrison TS, Fajans SS, Floyd JC Jr: Prevalence of diffuse pancreatic beta islet cell disease with hyperinsulinism - problems in recognition and management. World J Surg 1984; 8: 583-9.
21. Ariel I, Kerem E, Schwartz-Arad D, et al.: Nesidiodisplasia - a histologic entity? Hum Pathol 1988; 19: 1215-8.
22. Fajans SS, Vinik Al: Insulin producing islet cell tumors. Endocrinol Metab Clin North Am 1989; 18: 45-74.
23. Porte D, Kahn S: Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta cell dysfunction. Diabetes 1989; 38: 1336-6.
24. O'Brien T, Butler A, Roche P, Johnson K, Butyler P: Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes 1994; 43: 329-36.
25. Boden G, Murer E, Mozzoli M: Glucose transporter proteins in human insulinoma. Ann Intern Med 1994; 121: 109-11.
26. Seino Y, Yamamoto T, Kazutomo Y, et al.: Abnormal facilitative glucose transporter gene expression in human islet cell tumors. J Clin Endocrinol Metab 1993; 76: 75-8.
27. Battezatti A, Terruzzi Y, Perseghin G, Bianchi E, Di Carlo V, Pozza G: Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma. Diabetes 1995; 44: 837-44.
28. Skrha J, Sindelka G, Haas T, Hilgertora J, Justora V: Comparison of insulin sensitivity in patients with insulinoma and obese type 2 diabetes mellitus. Horm Metab Res 1996; 28: 595-8.
29. Steinke J: Hypoglycemia. In, Marble A, White P, Bradley RF, Krall LP: Joslin's Diabetes Mellitus. Philadelphia, Lea and Febiger 1971: 797-516.
30. Wang R, Kloppel G, Bouwensl L: Duct to islet cell differentiation and islet growth in the pancreas of duct ligated adult rats. Diabetologia 1995; 38: 1405-11.
31. Beard JC, Ward WK, Halter JB, Wallum BJ, Porte D: Relationship of islet function to insulin action in human obesity. J Clin Endocrinol Metab 1987; 65: 59-64.
32. Mandarino L, Tsaliklan E, Bartold S, et al.: Mechanism of hyperglycemia and response to treatment with an inhibitor of fatty acid oxidation in a patient with insulin resistance due to antiinsulin receptor antibodies. J Clin Endocrinol Metab 1984; 59: 658-64.
33. O'Brien T, Rizza R, Carney A, Butler P: Islet amyloidosis in a patient with chronic massive insulin resistance due to atiinsulin receptor antibodies. J Clin Endocrinol Metab 1994; 79: 290-2.
34. Warren S, LeCompte P, Legg M: Infants of diabetic mothers. In The Pathology of Diabetes Mellitus. Philadelphia, Lea and Febiger 1966: 406-18.
35. Friedlander E: Hyperinsulinism secondary to disease of the pancreas and organs adjacent to the pancreas: a review of the world literature. Ann Intern Med 1960; 52: 838-48.
36. Bloodworth JM: Morphologic changes associated with sulfonylurea therapy. Metabolism 1990; 12: 287-301.